Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...
Synthetic biology specialist GRO Biosciences is exploring strategic alternatives about six months after raising a series B ...
X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in T-cell, B-cell, and natural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback